How is IHL able to do directly Phase 2 in Psychedelics trials and not have to do phase 1? Appreciate some enlightenment.Btw, good portal have visibility:https://psilocybinalpha.com/data/psychedelic-drug-development-tracker
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint